Companies that staff call centers, back offices and data-analytics teams on behalf of other businesses have spent the past year being priced as artificial intelligence's most direct casualty — every chatbot that answers a customer call is a job these firms used to sell by the hour. Five of the largest publicly traded names in that business rose an average of 12.5% over the past 30 days even as their one-year return remains deeply negative. But the rally is not evidence the market has decided AI fears were overdone across the board: it is concentrated in two companies that actually reported accelerating, AI-led revenue growth, while the sector's weakest and strongest fundamental performers each moved in ways a simple "AI reprieve" story wouldn't predict.

The AI-disruption backdrop is real. Swedish fintech Klarna disclosed that its AI assistant now handles the workload of roughly 700 full-time contact-center agents, and shares of European outsourcer Teleperformance fell 29.3% in a single day on the read-through. Research firm Gartner projects contact centers will need 30-40% fewer human agents for the same call volume by 2026, cutting an estimated $80 billion from industry labor costs, and consulting giant Capgemini closed a $3.3 billion acquisition of outsourcer WNS last October — a consolidation move that only makes sense if standalone scale in this business is eroding. That is the backdrop against which July's bounce has to be judged.

ExlService Holdings (EXLS), a data-analytics and digital-operations firm serving insurance, healthcare and banking clients, led the group with a 27.6% 30-day gain after its July 29 second-quarter report. Revenue grew 16% year over year to $594.8 million, beating estimates, and the company raised full-year guidance to $2.39-$2.415 billion. Crucially, data- and AI-led services now make up 61% of total revenue and grew 30% year over year — a faster clip than the legacy analytics base, and EXL is closing an acquisition of AI data-annotation firm iMerit to extend that lead. Revenue growth has accelerated for four straight quarters (12.2% to 15.6% year over year), and forward price-to-earnings of 14.96x sits well below its trailing 21.53x, implying the market expects more of this growth to show up in earnings. The business explains the move.

Genpact (G), a Bermuda-based business-process and IT-services firm serving banking, insurance and manufacturing clients, gained 22.1% in price over 30 days on genuinely strong numbers: first-quarter revenue grew 6.7% to $1.296 billion with operating margin expanding to 16.1% from 15.1%. Its Advanced Technology Solutions segment — data, AI and "agentic" automation — grew 24% year over year and now represents 27% of revenue; first-quarter agentic bookings alone nearly matched all of 2025's total contract value, a year that closed with a record $5.5 billion in new bookings. At 8.63x forward earnings and 8.17x trailing enterprise value to EBITDA, Genpact remains the cohort's cheapest name even after the rally.

NIQ Global Intelligence (NIQ), a Nielsen spinoff that sells consumer-shopping and retail-measurement subscriptions, rose 17.0% on Buy ratings from Stifel and Barclays, a new AI-focused executive hire, and a new retail-data agreement with Circle K — but its next earnings report isn't due until August 10, so this move is running ahead of any confirming numbers. The company's most recent reported quarter showed revenue growth decelerating sharply to 1.3% year over year from 23.4% a year earlier, the cohort's clearest organic slowdown, even as a 2025 refinancing of $3.4 billion in debt cut annual interest expense by nearly $100 million.

Concentrix (CNXC), the largest pure contact-center and back-office outsourcer in the group, is the name most directly exposed to "AI answers the call we used to staff," and its stock managed only a 5.7% 30-day gain — the weakest in the cohort, and still down roughly 46% over the past year. The numbers explain why: constant-currency revenue grew just 0.6% last quarter, gross margin fell to 33.4% from 35.1%, operating income dropped 35.7%, and the company cut full-year guidance citing accelerating client offshoring. Its AI platform, IX Suite, is targeting only about $120 million in annual recurring revenue against roughly $10 billion in total revenue. A forward price-to-earnings ratio near 2x looks cheap only because heavy debt from its Webhelp acquisition and a prior $1.48 billion impairment have crushed the equity value underneath it.

Innodata (INOD), a data-engineering firm that builds AI training and evaluation datasets for hyperscale cloud customers, is the cohort's inversion: the strongest fundamentals, the weakest recent stock. Revenue grew 54.4% year over year last quarter with gross margin expanding to 43.4%, and business from customers outside its top client grew 453% year over year, chipping at a customer-concentration risk that still sees one client generate roughly 57% of revenue. Yet the stock fell 7.9% over the past 30 days after nearly doubling earlier in 2026, and trades at 58.6x forward earnings and 34.3x trailing EBITDA — three to five times richer than any peer here. This looks like valuation digestion after a run, not a fundamental reversal.

On the tape, the divergence between price and trend is the story: EXLS and NIQ both flipped from a locked-in downtrend to neutral around their catalysts, a genuine multi-step repair for NIQ (strong downtrend to mild downtrend to neutral across July). Genpact's trend indicator, by contrast, has stayed pinned in its worst downtrend category continuously since March 9 despite the 22% price gain — a clean divergence between the business, which is improving, and a chart that hasn't caught up. Concentrix's downtrend never broke at all.

The setup

Where it stands — EXL and Genpact show accelerating, named AI-led revenue and re-rated multiples; Concentrix's core business is still shrinking; Innodata and NIQ await confirmation. Would confirm — EXL's data/AI-led revenue mix keeps growing above 25% year over year for two more quarters while total company margins hold or expand. Would invalidate — Genpact's Advanced Technology Solutions growth decelerates back toward its legacy blended rate, or its trend indicator fails to exit its downtrend despite the price gain. Watch next — NIQ reports second-quarter results August 10, the first real test of whether its 17% rally has fundamental support. Valuation — EXL trades at 14.96x forward earnings versus 21.53x trailing; Genpact at 8.63x forward versus 8.17x trailing EV/EBITDA, both near multi-year lows.